The p-tau217 biomarker, which could help with early diagnosis of dementia, showed big differences depending on the time of ...
Over the next 12 months, Parker and his team, as part of the Fellowship, will work with EptivA Therapeutics, a clinical-stage biotechnology company, to research a new personalised medication for those ...
His Royal Highness The Duke of Gloucester toured the University of Surrey's state-of-the-art oncology research labs.
The MESOM spacecraft will fly on a peculiar trajectory enabled by the gravitational attraction of the Earth, the Sun and the Moon, and will use the shadow of the Moon to re-create a total solar ...